Philippe Moingeon is a member of the Academy of Pharmacy. Associate Professor of Artificial Intelligence and Pharmaceutical Sciences at Paris-Saclay University.
Artificial intelligence (AI) is profoundly changing the way we approach the design of new medicines, with today’s concrete achievements and dizzying prospects. Advances in artificial intelligence over the past five years have made it an important tool in academic and industrial laboratories dedicated to drug research. This revolution is not limited to specialized circles, but affects each of us, fundamentally changing the way we think about diseases.
The result of more than seventy years of research, AI today takes advantage of the computing power of modern computers and access to vast amounts of data. It represents a convergence of technologies aimed at creating machines inspired by the human brain that can perceive, analyze…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.